BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30225956)

  • 1. Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study.
    Gori M; Redfield MM; Calabrese A; Canova P; Cioffi G; De Maria R; Grosu A; Fontana A; Iacovoni A; Ferrari P; Parati G; Gavazzi A; Senni M
    Eur J Heart Fail; 2018 Nov; 20(11):1540-1548. PubMed ID: 30225956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study].
    Gavazzi A; De Maria R; Grosu A; Iacovoni A; Fontana A; Gori M; Ferrari P; Canova P; Calabrese A; Filippi A; Rutili MR; Donzelli L; Parolini M; Senni M
    G Ital Cardiol (Rome); 2014 May; 15(5):313-22. PubMed ID: 25002172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratifying asymptomatic left ventricular systolic dysfunction in the community: beyond left ventricular ejection fraction.
    Burocchi S; Gori M; Cioffi G; Calabrese A; Canova P; De Maria R; Grosu A; Fontana A; Iacovoni A; Ferrari P; Volpe M; De Biase L; Parati G; Gavazzi A; Senni M
    Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1405-1411. PubMed ID: 31808506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right atrial volume index in chronic systolic heart failure and prognosis.
    Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL
    JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular ejection fraction for risk stratification in chronic systolic heart failure.
    Aimo A; Januzzi JL; Vergaro G; Petersen C; Pasanisi EM; Molinaro S; Passino C; Emdin M
    Int J Cardiol; 2018 Dec; 273():136-140. PubMed ID: 30057167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study).
    Pandhi J; Gottdiener JS; Bartz TM; Kop WJ; Mehra MR
    Am J Cardiol; 2011 Jun; 107(11):1667-74. PubMed ID: 21575752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects.
    Gori M; Lam CSP; D'Elia E; Iorio AM; Calabrese A; Canova P; Cioffi G; De Maria R; Ghirardi A; Iacovoni A; Grosu A; Fontana A; Ferrari P; Parati G; Gavazzi A; Senni M
    Eur J Prev Cardiol; 2021 Aug; 28(9):937-945. PubMed ID: 34402871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.
    Echouffo-Tcheugui JB; Erqou S; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 Apr; 4(4):237-48. PubMed ID: 26682794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).
    Yeboah J; Rodriguez CJ; Stacey B; Lima JA; Liu S; Carr JJ; Hundley WG; Herrington DM
    Circulation; 2012 Dec; 126(23):2713-9. PubMed ID: 23124035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.
    Wang Y; Yang H; Huynh Q; Nolan M; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1390-1400. PubMed ID: 29778859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading of Left Ventricular Diastolic Dysfunction with Preserved Systolic Function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Recommendations Contributes to Predicting Cardiovascular Events in Hemodialysis Patients.
    Toida T; Toida R; Yamashita R; Komiya N; Uezono S; Komatsu H; Ishikawa T; Kitamura K; Sato Y; Fujimoto S
    Cardiorenal Med; 2019; 9(3):190-200. PubMed ID: 30844787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes.
    Gregers MCT; Schou M; Jensen MT; Jensen J; Petrie MC; Vilsbøll T; Goetze JP; Rossing P; Jørgensen PG
    Scand Cardiovasc J; 2022 Dec; 56(1):256-263. PubMed ID: 35811473
    [No Abstract]   [Full Text] [Related]  

  • 15. Independent and incremental prognostic value of Doppler-derived left ventricular total isovolumic time in patients with systolic heart failure.
    Bajraktari G; Dini FL; Fontanive P; Elezi S; Berisha V; Napoli AM; Ciuti M; Henein M
    Int J Cardiol; 2011 May; 148(3):271-5. PubMed ID: 19948365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.
    Persson H; Lonn E; Edner M; Baruch L; Lang CC; Morton JJ; Ostergren J; McKelvie RS;
    J Am Coll Cardiol; 2007 Feb; 49(6):687-94. PubMed ID: 17291934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value.
    Verdecchia P; Angeli F; Gattobigio R; Sardone M; Porcellati C
    Hypertension; 2005 Mar; 45(3):412-8. PubMed ID: 15655115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive role of diastolic dysfunction and ventricular remodeling in asymptomatic subjects at increased risk of heart failure.
    Fabiani I; Pugliese NR; La Carrubba S; Conte L; Colonna P; Caso P; Benedetto F; Antonini-Canterin F; Citro R; Dini FL; Carerj S; Di Bello V;
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1231-1240. PubMed ID: 30815808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.